Goflikicept (RPH 104) is a fusion protein that selectively binds and inactivates both circulating IL-1beta and IL-1alpha. Goflikicept has the potential for the research of ST-segment elevation myocardial infarction (STEMI)[1].
Molecular Weight:
(126.22 kDa)
Purity:
98.32
CAS Number:
[2416984-26-2]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
